| Literature DB >> 34065001 |
Dominika Stygar1, Aleksandra Pogorzelska2, Elżbieta Chełmecka3, Bronisława Skrzep-Poloczek1, Barbara Bażanów2, Tomasz Gębarowski4, Jerzy Jochem1, Jiří Henych5.
Abstract
Since biological applications and toxicity of graphene-based materials are structure dependent, studying their interactions with the biological systems is very timely and important. We studied short-term (1, 24, and 48 h) effects of ultrapure (GO) and Mn2+-contaminated (GOS) graphene oxide on normal human dermal fibroblasts (NHDF) and adenocarcinomic human alveolar basal epithelial cells (A549) using selected oxidative stress markers and cytokines: glutathione reductase (GR) and catalase (CAT) activity, total antioxidative capacity (TAC), and malondialdehyde (MDA) concentration, levels of vascular endothelial growing factor (VEGF), tumor necrosis factor-alpha (TNF-α), platelet-derived growth factor-BB (PDGF-BB), and eotaxin. GOS induced higher levels of oxidative stress, measured with CAT activity, TAC, and MDA concentration than GO in both cell lines when compared to control cells. GR activity decreased in time in NHDF cells but increased in A549 cells. The levels of cytokines were related to the exposure time and graphene oxide type in both analyzed cell lines and their levels comparably increased over time. We observed higher TNF-α levels in NHDF and higher levels of VEGF and eotaxin in the A549 cell line. Both types of cells showed similar susceptibility to GO and GOS. We concluded that the short-time exposure to GOS induced the stronger response of oxidative stress markers without collapsing the antioxidative systems of analysed cells. Increased levels of inflammatory cytokines after GO and GOS exposure were similar both in NHDF and A549 cells.Entities:
Keywords: A549; GO; NHDF; cytokines; graphene oxide; graphene-based materials; oxidative stress markers
Year: 2021 PMID: 34065001 PMCID: PMC8151183 DOI: 10.3390/antiox10050765
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Oxidative stress markers’ levels in NHDF (normal human dermal fibroblasts) and A549 (adenocarcinomic human alveolar basal epithelial cells) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS). Categorical factors: time (time passed from exposition to GO/GOS to samples’ collection), factor (GO or GOS vs. control group); int. (interaction between time and type of factor (GO vs. GOS)). The results are presented as mean ± standard deviation. Statistical significance was set at a p < 0.05.
| Oxidative Stress Marker | Group | NHDF Cell Line | A549 Cell Line | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 h | 24 h | 48 h | ptime | pfactor | pint. | 1 h | 24 h | 48 h | ptime | pfactor | pint. | ||
| GR | control | 0.96 ± 0.04 | 0.74 ± 0.01 | 1.53 ± 0.01 | <0.001 | <0.001 | <0.001 | 2.95 ± 0.02 | 2.49 ± 0.01 | 4.12 ± 0.15 | <0.001 | – | <0.001 |
| GO | 1.27 ± 0.02 | 1.67 ± 0.01 | 1.87 ± 0.01 | 2.78 ± 0.01 | 5.14 ± 0.05 | 7.54 ± 0.03 | |||||||
| GOS | 1.62 ± 0.01 | 1.18 ± 0.04 | 0.57 ± 0.02 | 5.56 ± 0.04 | 6.64 ± 0.02 | 9.47 ± 0.02 | |||||||
| CAT | control | 0.32 ± 0.02 | 0.19 ± 0.02 | 0.17 ± 0.03 | <0.001 | – | <0.001 | 0.41 ± 0.11 | 0.48 ± 0.04 | 0.35 ± 0.03 | <0.001 | <0.001 | <0.001 |
| GO | 1.13 ± 0.02 | 1.28 ± 0.02 | 1.13 ± 0.02 | 1.68 ± 0.01 | 1.30 ± 0.03 | 1.77 ± 0.02 | |||||||
| GOS | 1.17 ± 0.02 | 1.31 ± 0.03 | 1.31 ± 0.04 | 1.27 ± 0.02 | 1.70 ± 0.05 | 1.91 ± 0.05 | |||||||
| TAC | control | 0.24 ± 0.01 | 0.25 ± 0.03 | 0.25 ± 0.05 | 0.192 | <0.001 | 0.072 | 0.25 ± 0.02 | 0.25 ± 0.02 | 0.22 ± 0.01 | <0.001 | < 0.001 | <0.001 |
| GO | 0.14 ± 0.02 | 0.16 ± 0.01 | 0.14 ± 0.02 | 0.22 ± 0.03 | 0.21 ± 0.01 | 0.18 ± 0.01 | |||||||
| GOS | 0.14 ± 0.01 | 0.13 ± 0.01 | 0.15 ± 0.03 | 0.20 ± 0.02 | 0.13 ± 0.01 | 0.14 ± 0.01 | |||||||
| MDA | control | 0.30 ± 0.08 | 0.16 ± 0.02 | 0.19 ± 0.02 | <0.001 | <0.001 | <0.001 | 0.16 ± 0.02 | 0.15 ± 0.02 | 0.14 ± 0.02 | <0.001 | – | <0.001 |
| GO | 1.60 ± 0.06 | 1.92 ± 0.02 | 1.63 ± 0.08 | 1.07 ± 0.03 | 1.32 ± 0.05 | 1.24 ± 0.08 | |||||||
| GOS | 1.40 ± 0.01 | 2.17 ± 0.02 | 2.39 ± 0.05 | 1.38 ± 0.04 | 1.60 ± 0.02 | 1.76 ± 0.08 | |||||||
Abbreviations: A549, adenocarcinomic human alveolar basal epithelial cells cell line; CAT, catalase activity; GR, glutathione reductase activity; GO, ultrapure graphene oxide; GOS, graphene oxide contaminated with manganese ions; MDA, malondialdehyde concentration; NHDF, normal human dermal fibroblasts cell line; TAC, total antioxidant capacity.
Figure 1Oxidative stress markers in the NHDF (normal human dermal fibroblasts) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS): (A) glutathione reductase (GR) activity (IU/L), (B) catalase (CAT) activity (IU/L), (C) total antioxidant capacity (TAC) (mmol/L), (D) malondialdehyde (MDA) concentration (μmol/g protein). The markers present mean value of the analyzed parameter.
Figure 2Oxidative stress markers in the in the A549 (adenocarcinomic human alveolar basal epithelial cells) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS): (A) glutathione reductase (GR) activity (IU/L), (B) catalase (CAT) activity (IU/L), (C) total antioxidant capacity (TAC) (mmol/L), (D) malondialdehyde (MDA) concentration (μmol/g protein). The markers present mean value of the analyzed parameter.
Cytokines levels in NHDF (normal human dermal fibroblasts) and in A549 (adenocarcinomic human alveolar basal epithelial cells) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS). Categorical factors: time (time passed from exposition to GO/GOS to samples collection), factor (GO or GOS vs. control group), int. (interaction between time and type of factor (GO vs. GOS)). The results are presented as mean ± standard deviation. Statistical significance was set at a p < 0.05.
| Cytokines Concentration | Group | NHDF Cell Line | A549 Cell Line | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 h | 24 h | 48 h | ptime | pfactor | pint. | 1 h | 24 h | 48 h | ptime | pfactor | pint. | ||
| VEGF | Control | 68.0 ± 0.9 | 75.8 ± 0.7 | 102.1 ± 1.3 | <0.001 | <0.001 | <0.001 | 32.8 ± 0.6 | 55.3 ± 1.0 | 123.4 ± 1.3 | <0.001 | <0.001 | <0.001 |
| GO | 117.2 ± 0.6 | 153.7 ± 1.0 | 178.3 ± 2.0 | 135.9 ± 1.1 | 160.2 ± 0.5 | 351.0 ± 0.9 | |||||||
| GOS | 132.9 ± 1.8 | 213.7 ± 0.8 | 283.3 ± 1.4 | 178.8 ± 0.8 | 265.8 ± 0.9 | 323.9 ± 0.7 | |||||||
| TNF-α | Control | 125.5 ± 16.1 | 218.8 ± 26.1 | 283.5 ± 18.5 | <0.001 | <0.001 | <0.001 | 158.3 ± 11.8 | 161.3 ± 9.9 | 248.7 ± 29.8 | <0.001 | <0.001 | <0.001 |
| GO | 441.3 ± 37.0 | 550.2 ± 45.7 | 736.3 ± 28.7 | 357.5 ± 22.2 | 370.2 ± 38.2 | 726.3 ± 15.5 | |||||||
| GOS | 477.7 ± 47.7 | 1008.5 ± 21.1 | 966.8 ± 55.8 | 625.5 ± 11.6 | 817.0 ± 35.5 | 934.5 ± 20.9 | |||||||
| PDGF-BB | Control | 1606.7 ± 51.9 | 5306.3 ± 67.7 | 6725.0 ± 152.5 | <0.001 | <0.001 | <0.001 | 1304.8 ± 7.7 | 2117.8 ± 12.0 | 3134.8 ± 25.4 | <0.001 | <0.001 | <0.001 |
| GO | 3267.8 ± 84.1 | 6212.5 ± 101.6 | 6864.3 ± 43.6 | 3512.0 ± 9.2 | 5248.8 ± 19.8 | 6206.3 ± 142.3 | |||||||
| GOS | 5746.0 ± 75.1 | 6462.7 ± 124.7 | 7171.8 ± 96.9 | 5334.8 ± 103.1 | 6954.8 ± 93.8 | 7807.7 ± 74.3 | |||||||
| Eotaxin | Control | 88.0 ± 10.1 | 99.7 ± 16.2 | 191.0 ± 22.0 | <0.001 | <0.001 | <0.001 | 186.2 ± 10.8 | 159.8 ± 12.9 | 169.3 ± 19.4 | <0.01 | <0.001 | <0.001 |
| GO | 149.0 ± 41.2 | 271.3 ± 34.6 | 331.7 ± 36.0 | 229.7 ± 21.1 | 262.8 ± 22.8 | 251.2 ± 6.2 | |||||||
| GOS | 167.7 ± 18.0 | 242.3 ± 34.9 | 437.0 ± 39.2 | 266.3 ± 25.6 | 257.8 ± 28.2 | 323.0 ± 3.2 | |||||||
Abbreviations: A549, adenocarcinomic human alveolar basal epithelial cells; GO, ultrapure graphene oxide; GOS, graphene oxide contaminated with manganese ions; NHDF, normal human dermal fibroblasts cell line; PDGF-BB, platelet-derived growth factor-BB; TNF-α, tumor necrosis factor-alpha; VEGF, vascular endothelial growing factor.
Figure 3Cytokines’ concentrations (pg/mL) in the NHDF (normal human dermal fibroblasts) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS): (A) vascular endothelial growing factor (VEGF), (B) tumor necrosis factor-alpha (TNF-α), (C) platelet-derived growth factor-BB (PDGF-BB), (D) eotaxin. The markers present mean value of the analyzed parameter.
Figure 4Cytokines’ concentration (pg/mL) in the A549 (adenocarcinomic human alveolar basal epithelial cells) cell line measured 1, 24, and 48 h after exposure to ultrapure (GO) or manganese ions-contaminated graphene oxide (GOS): (A) vascular endothelial growing factor (VEGF), (B) tumor necrosis factor-alpha (TNF-α), (C) platelet-derived growth factor-BB (PDGF-BB), (D) eotaxin. The markers present mean value of the analyzed parameter.